A Study Comparing CoQ10 Levels While Taking 3 Different Statins

Completed · Phase 4

Conditions studied: Hypercholesterolemia

In brief

The purpose of this study is to determine if Pitavastatin lowers CoQ10 less than Atorvastatin or Rosuvastatin.

Key facts

Study ID

NCT01660191

Run by

University of Kansas Medical Center

People needed

134

Starts

2011-12-01

Expected to finish

2013-10-01

Last updated by the study team

2017-01-18

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• LDL-C levels of 100-200mg/dl; triglycerides </=200mg/dl at screening visit
• Willing to discontinue use of all lipid-altering doses fo medication or supplements for the duration of the study

You may not qualify if…

• LDL-C <100mg/dl or >200mg/dl, Triglycerides >200mg/dl
• History of diabetes mellitus or documented fasting blood glucose >125mg/dl or HbA1c >6.4%
• History of coronary artery disease
• history of chronic renal or hepatic disease
• known sensitivity of intolerance to a statin
• persistent elevated liver enzymes or CPK (>3 x upper normal limit)
• currently taking CoQ10 supplements and unable discontinue for duration of study

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.